| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/2006 | US20060083734 Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 04/20/2006 | US20060083733 High-concentration preparation of soluble thrombomodulin |
| 04/20/2006 | US20060083732 Hyaluronic acid in the enhancement of lens regeneration |
| 04/20/2006 | US20060083731 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 04/20/2006 | US20060083730 Method for treatment of osteochondral and bone defects using an acellular matrix implant |
| 04/20/2006 | US20060083729 Biocompatible tissue sealant for treatment of osteochondral and bone defects using an acellular matrix implant |
| 04/20/2006 | US20060083728 Acellular matrix implant for treatment of cartilage lesions, injuries and defects |
| 04/20/2006 | US20060083727 Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| 04/20/2006 | US20060083724 Compositions for the treatment of femal sexual dysfunction |
| 04/20/2006 | US20060083717 System and method for forming a non-ablative cardiac conduction block |
| 04/20/2006 | US20060083715 Interferon beta-like molecules for treatment of stroke |
| 04/20/2006 | US20060083714 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 04/20/2006 | US20060083713 Methods of using a human il-17 related polypeptide to treat disease |
| 04/20/2006 | US20060083712 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | DE3991505B4 Somatostatinpeptide, deren Analoga oder Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Somatostatin peptides, their analogues or derivatives, to processes for their preparation and pharmaceutical compositions containing them |
| 04/20/2006 | DE102004049223A1 Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung Preparation for seeding, seeding and use of a vaccine preparation |
| 04/20/2006 | CA2585832A1 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 04/20/2006 | CA2584293A1 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 04/20/2006 | CA2584261A1 Pharmaceutical composition |
| 04/20/2006 | CA2584095A1 Vasoactive intestinal polypeptide pharmaceuticals |
| 04/20/2006 | CA2583670A1 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 04/20/2006 | CA2583243A1 Promotion of cell migration and axon regeneration in the cns |
| 04/20/2006 | CA2583230A1 Compositions and methods for treating disease |
| 04/20/2006 | CA2583004A1 Methods of inhibiting cell death or inflammation in a mammal |
| 04/20/2006 | CA2582769A1 Solid phase peptide sythesis |
| 04/20/2006 | CA2582713A1 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 04/20/2006 | CA2582353A1 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
| 04/20/2006 | CA2582228A1 Method for diagnosing and treating crohn's disease |
| 04/20/2006 | CA2582149A1 Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels |
| 04/20/2006 | CA2580991A1 Amylin family polypeptide-6 (afp-6) analogs and methods of making and using them |
| 04/20/2006 | CA2580766A1 Use of organic compounds |
| 04/20/2006 | CA2550452A1 Immortalized hepatocytes |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1647556A1 Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors |
| 04/19/2006 | EP1647292A1 Needleless syringe having medical agent accommodated therein |
| 04/19/2006 | EP1647280A2 Composition for promoting development of nervous system |
| 04/19/2006 | EP1647279A2 Inhibition of apoptosis using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors |
| 04/19/2006 | EP1646869A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/19/2006 | EP1646716A1 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 04/19/2006 | EP1646651A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 04/19/2006 | EP1646646A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 04/19/2006 | EP1646645A1 Antigenic peptides of sars coronavirus and uses thereof |
| 04/19/2006 | EP1646643A2 C5a receptor antagonists |
| 04/19/2006 | EP1646631A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 04/19/2006 | EP1646445A2 Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation |
| 04/19/2006 | EP1646399A2 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases. |
| 04/19/2006 | EP1646398A2 Formulations comprising factor viia and a factor vii related polypeptide |
| 04/19/2006 | EP1646397A1 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES |
| 04/19/2006 | EP1646396A2 Use of soluble cd164 in inflammatory and/or autoimmune disorders |
| 04/19/2006 | EP1646395A2 Methods and compositions for regulating lymphocyte activity |
| 04/19/2006 | EP1646381A2 Combination therapy for treating chronic inflammatory diseases |
| 04/19/2006 | EP1646366A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 04/19/2006 | EP1646353A2 Fusion proteins for the treatment of cns |
| 04/19/2006 | EP1646352A2 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/19/2006 | EP1531846A4 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 04/19/2006 | EP1521523A4 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues |
| 04/19/2006 | EP1481002B1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 04/19/2006 | EP1436005A4 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/19/2006 | EP1385871B1 Process for inactivating prions in lipoproteins |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1292187B1 Transgenic animal model of neurodegenerative disorders |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1255452B1 A method for maintaining or improving the synthesis of mucins |
| 04/19/2006 | EP1246640B1 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 04/19/2006 | EP1206313A4 Preparation of a therapeutic composition |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP1121381B1 Zinc finger binding domains for gnn |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1103561B1 Hla-a2 restraint tumor antigen peptide originating in sart-1 |
| 04/19/2006 | EP1100820B1 Pectic substance as a growth factor stabilizer |
| 04/19/2006 | EP1039934B1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0873417B1 Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/19/2006 | EP0873355B1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 04/19/2006 | EP0812352B1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 04/19/2006 | EP0811064B1 Mpl ligand analogs |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | EP0776370B1 Human erythropoietin receptor fragment and antibodies thereto |
| 04/19/2006 | CN1761760A Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long Q/T syndrome |
| 04/19/2006 | CN1761747A Method for the production of GLA-residue containing serine proteases |
| 04/19/2006 | CN1761744A Cultured CD14+ antigen presenting cells |
| 04/19/2006 | CN1761686A Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/19/2006 | CN1761681A Regulation of gene expression |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1761481A Osteogenic composition |
| 04/19/2006 | CN1761480A APLIDINE for multiple myeloma treatment |
| 04/19/2006 | CN1761479A Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 04/19/2006 | CN1761478A Combination therapy for the treatment of immunoinflammatory disorders |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1761472A Regulation of cell surface proteins |
| 04/19/2006 | CN1761471A Combined use of ribavirin and interferon beta in demyelinating diseases |
| 04/19/2006 | CN1761403A Method and compositions for improving animal health |
| 04/19/2006 | CN1760363A Coded sequence of reductase enzyme protein of eucommia 3-hydroxy-3-coenzyme of methyl glutaryl A |
| 04/19/2006 | CN1760362A Gene clone and expression of RGD die body protein of oral gland in Japan lamprey possessing function for anti tumour |
| 04/19/2006 | CN1760210A Fusion protein possessing function of weight reduction, coded gene and application |
| 04/19/2006 | CN1760209A Interfusion protein of human interleukin 15 and Fe |
| 04/19/2006 | CN1760205A Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 04/19/2006 | CN1760203A Antibacterial tripeptides and modified chemicals, and application |